apoE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes

Neuroscience

Volumn 122, Issue 2, 2003, Pages 291-303

  Qiu, Z ^a   Crutcher, K A ^b   Hyman, B T ^a   Rebeck, G W ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Calcium; Fluo 3; Hippocampus; Lipoprotein; 2 macroglobulin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; DIZOCILPINE; LACTATE DEHYDROGENASE; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; EMBRYO; HIPPOCAMPUS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0242570611     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.08.017     Document Type: Article

References (66)

1. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death a succession of necrosis or apoptosis depending on mitochondrial function . Neuron. 15:1995;961-973.
2. Aono M., Bennett E.R., Kim K.S., Lynch J.R., Myers J., Pearlstein R.D., Warner D.S., Laskowitz D.T. Protective effect of apolipoprotein E-mimetic peptides on N-methyl-D-aspartate excitotoxicity in primary rat neuronal-glial cell cultures. Neuroscience. 116:2003;437-445.
3. Bacskai B.J., Xia M.Q., Strickland D.K., Rebeck G.W., Hyman B.T. The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA. 97:2000;11551-11556.
4. Battey F.D., Gafvels M.E., FitzGerald D.J., Argraves W.S., Chappell D.A., Strauss J.F.I.I.I., Strickland D.K. The 39 kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. J Biol Chem. 269:1994;23268-23273.
5. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go R.C.P., Perry R., Watson B., Bassett S.S., McInnis M.G., Albert M.S., Hyman B.T., Tanzi R.E. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet. 19:1998;357-360.
6. Bu G., Maksymovitch E.A., Nerbonne J.M., Schwartz A.L. Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J Biol Chem. 269:1994;18521-18528.
7. Buttini M., Orth M., Bellosta O. Expression of human apolipoprotein E3 or E4 in the brains of apoe -/- mice: isoform specific effects on neurodegeneration. J Neurosci. 19:1999;4867-4880.
8. Choi D.W. Excitotoxic cell death. J Neurobiol. 23:1992;1261-1276.
9. Christie R.H., Chung H., Rebeck G.W., Strickland D., Hyman B.T. Expression of the very low density lipoprotein receptor (VLDL-r), an apolipoprotein E receptor, in the central nervous system and in Alzheimer disease. J Neuropath Exp Neurol. 55:1996;491-498.
10. Christopherson K.S., Hillier B.J., Lim W.A., Bredt D.S. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem. 274:1999;27467-27473.
11. Clatworthy AE, Stockinger W, Christie RH, Schneider WJ, Nimpf J, Hyman BT, Rebeck GW (1998) Expression and alternate splicing of apoE receptor 2 in brain. Neuroscience 90:903-910.
12. Crutcher K.A., Clay M.A., Scott S.A., Tian X., Tolar M., Harmony J.A. Neurite degeneration elicited by apolipoprotein E peptides. Exp Neurol. 130:1994;120-126.
13. den Heijer T., Oudkerk M., Launer L.J., van Duijn C.M., Hofman A., Breteler M.M. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology. 59:2002;746-748.
14. Du Y., Bales K.R., Dodel R.C., Liu X., Glinn M.A., Horn J.W., Little S.P., Paul S.M. α2-Macroglobulin attenuates β-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J Neurochem. 70:1998;1182-1188.
15. Gibbons S.J., Brorson J.R., Bleakman D., Chard P.S., Miller R.J. Calcium influx and neurodegeneration. Ann NY Acad Sci. 679:1993;22-23.
16. Gotthardt M., Trommsdorff M., Nevitt M.F., Shelton J., Richardson J.A., Stockinger W., Nimpf J., Herz J. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J Biol Chem. 275:2000;25616-25624.
17. Hagiwara A., Hashimoto Y., Niikura T., Ito Y., Terashita K., Kita Y., Nishimoto I., Umezawa K. Neuronal cell apoptosis by a receptor-binding domain peptide of ApoE4, not through low-density lipoprotein receptor-related protein. Biochem Biophys Res Commun. 278:2000;633-639.
18. Hardingham G.E., Fukunaga Y., Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 5:2002;405-414.
19. Hashimoto Y., Jiang H., Niikura T., Ito Y., Hagiwara A., Umezawa K., Abe Y., Murayama Y., Nishimoto I. Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases. J Neurosci. 20:2000;8401-8409.
20. Holtzman D.M., Pitas R.E., Kilbridge J., Nathan B., Mahley R.W., Bu G., Schwartz A.L. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci USA. 92:1995;9480-9484.
21. Huang Y., Liu X.Q., Wyss-Coray T., Brecht W.J., Sanan D.A., Mahley R.W. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci USA. 98:2001;8838-8843.
22. Jordan J., Galindo M.F., Miller R.J., Reardon C.A., Getz G.S., LaDu M.J. Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J Neurosci. 18:1998;195-204.
23. Kim D.H., Payne M.E., Levy R.M., MacFall J., Steffens D.C. APOE genotype and hippocampal volume change in geriatric depression. Biol Psychiatry. 51:2002;426-429.
24. Koh J.Y., Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods. 20:1987;83-90.
25. LaDu M.J., Pederson T.M., Frail D.E., Reardon C.A., Getz G., Falduto M.T. Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J Biol Chem. 270:1995;9039-9042.
26. Lei S., Czerwinska E.W.C., Walsh M.P., MacDonald J.F. Regulation of NMDA receptor activity by F-actin and myosin light chain kinase. J Neurosci Res. 21:2001;8464-8472.
27. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. New Engl J Med. 330:1994;613-622.
28. Mahley R.W. Apolipoprotein E cholesterol transport protein with expanding role in cell biology . Science. 240:1988;622-630.
29. Marques M.A., Tolar M., Crutcher K.A. Apolipoprotein E exhibits isoform-specific neurotoxicity. Alzheimers Res. 3:1997;1-6.
30. Marques M.A., Tolar M., Harmony J.A., Crutcher K.A. A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. Neuroreport. 7:1996;2529-2532.
31. Michikawa M., Yanagisawa K. Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death. J Neurochem. 72:1999;2278-2285.
32. Michikawa M., Yanagisawa K. Apolipoprotein E4 isoform-specific actions on neuronal cells in culture. Mech Ageing Dev. 107:1999;233-243.
33. Michikawa M., Fan Q.W., Isobe I., Yanagisawa K. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem. 74:2000;1008-1016.
34. Mielke R., Zerres K., Uhlhaas S., Kessler J., Heiss W.D. Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease. Neurosci Lett. 254:1998;49-52.
35. Minta A., Kao J.P.Y., Tsien R.Y. Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores. J Biol Chem. 264:1989;8171-8178.
36. Mori E., Lee K., Yasuda M., Hashimoto M., Kazui H., Hirono N., Matsui M. Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele. Ann Neurol. 51:2002;209-214.
37. Moulder K.L., Narita M., Chang L.K., Bu G., Johnson E.M.J. Analysis of a novel mechanism of neuronal toxicity produced by an apolipoprotein E-derived peptide. J Neurochem. 72:1999;1069-1080.
38. 2+-channel. Brain Pathol. 8:1998;641-653.
39. Narita M., Bu G., Holtzman D.M., Schwartz A.L. The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development. J Neurochem. 68:1997;587-595.
40. Ohkubo N., Mitsuda N., Tamatani M., Yamaguchi A., Lee Y.D., Ogihara T., Vitek M.P., Tohyama M. Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signal-regulated kinase pathway. J Biol Chem. 276:2001;3046-3053.
41. Olney J.W., Wozniak D.F., Farber N.B. Excitotoxic neurodegeneration in Alzheimer disease new hypothesis and new therapeutic strategies . Arch Neurol. 54:1997;1234-1240.
42. Pitas R.E., Boyles J.K., Lee S.H., Hui D., Weisgraber K.H. Lipoproteins and their receptors in the central nervous system. J Biol Chem. 262:1987;14352-14360.
43. Przewlocki R., Parsons K.L., Sweeney D.D., Trotter C., Netzeband J.G., Siggins G.R., Gruol D.L. Opioid enhancement of calcium oscillations and burst events involving NMDA receptors and L-type calcium channels in cultured hippocampal neurons. J Neurosci. 19:1999;9705-9715.
44. Qiu Z., Parsons K.L., Gruol D.L. Interleukin-6 selectively enhances the intracellular calcium response to NMDA in developing CNS neurons. J Neurosci. 15:1995;6688-6699.
45. Qiu Z., Sweeney D.D., Netzeband J.G., Gruol D. Chronic interleukin-6 alters NMDA receptor mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J Neurosci. 18:1998;10445-10456.
46. Qiu Z., Strickland D.K., Hyman B.T., Rebeck G.W. α2-Macroglobulin enhances the clearance of endogenous soluble β-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons. J Neurochem. 73:1999;1393-1398.
47. Qiu Z., Strickland D.K., Hyman B.T., Rebeck G.W. Elevation of LDL receptor-related protein levels via ligands interactions in Alzheimer's disease and in vitro. J Neuropathol Exp Neurol. 60:2001;430-440.
48. Qiu Z., Strickland D.K., Hyman B.T., Rebeck G.W. Alpha 2-macroglobulin exposure reduces calcium responses to NMDA via LDL receptor-related protein in cultured hippocampal neurons. J Biol Chem. 277:2002;14458-14466.
49. Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease allelic variation and receptor interactions . Neuron. 11:1993;575-580.
50. Rebeck G.W., Harr S.D., Strickland D.K., Hyman B.T. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the α2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann Neurol. 37:1995;211-217.
51. Reiman E.M., Caselli R.J., Chen K., Alexander G.E., Bandy D., Frost J. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease . Proc Natl Acad Sci USA. 98:2001;3334-3339.
52. Riemenschneider M., Schmolke M., Lautenschlager N., Vanderstichele H., Vanmechelen E., Guder W.G., Kurz A. Association of CSF apolipoprotein E, Abeta42 and cognition in Alzheimer's disease. Neurobiol Aging. 23:2002;205-211.
53. Roheim P.S., Carey M., Forte T., Vega G.L. Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci USA. 76:1979;4646-4649.
54. Sheng M. Excitatory synapses glutamate receptors put in their place . Nature. 386:1997;221-223.
55. Small G.W., Ercoli L.M., Silverman D.H., Huang S.C., Komo S., Bookheimer S.Y., Lavretsky H., Miller K., Siddarth P., Rasgon N.L., Mazziotta J.C., Saxena S., Wu H.M., Mega M.S., Cummings J.L., Saunders A.M., Pericak-Vance M.A., Roses A.D., Barrio J.R., Phelps M.E. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA. 97:2000;6037-6042.
56. Stockinger W., Hengstschlager-Ottnad E., Novak S., Matus A., Huttinger M., Bauer J., Lassmann H., Schneider W.J., Nimpf J. The low density lipoprotein receptor gene family differential expression of two alpha2-macroglobulin receptors in the brain . J Biol Chem. 273:1998;32213-32221.
57. Strickland D.S., Ashcom J.D., Williams S., Battey F., Behre E., McTigue K., Battey J.F., Argraves W.S. Primary structure of α2-macroglobulin receptor-related protein. J Biol Chem. 266:1991;13364-13369.
58. Tohgi H., Takahashi S., Kato E., Homma A., Niina R., Sasaki K., Yonezawa H., Sasaki M. Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. Neurosci Lett. 236:1997;21-24.
59. Tolar M., Marques M.A., Harmony J.A., Crutcher K.A. Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. J Neurosci. 17:1997;5678-5686.
60. Tolar M., Keller J.N., Chan S., Mattson M.P., Marques M.A., Crutcher K.A. Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. J Neurosci. 19:1999;7100-7110.
61. Veinbergs I., Eversonm A., Sagara Y., Masliah E. Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis. J Neurosci Res. 67:2002;379-387.
62. Weisgraber K.H. Apolipoprotein E structure-function relationships . Adv Prot Chem. 45:1994;249-302.
63. Williams S.E., Ashcom J.D., Argraves W.S., Strickland D.K. A novel mechanism for controlling the activity of α2-macroglobulin receptor/low density lipoprotein receptor-related protein. J Biol Chem. 267:1992;9035-9040.
64. Yu W.H., Fraser P.E. S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease. J Neurosci. 21:2001;2240-2246.
65. Zhang D., McQuade J.-A., Shockley K., Levin L., Marques M., Crutcher K. Proteolysis of apolipoprotein E and Alzheimer's disease pathology. Alzheimers Rep. 4:2001;67-80.
66. Zheng G., Bachinsky D.R., Stamenkovic I., Strickland D.K., Brown D., Andres G., McCluskey R.T. Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/α2MR, and the receptor-associated protein (RAP). J Histochem Cytochem. 42:1994;531-542.